Care Team Collaboration for CAR T-Cell Therapy: Real-World Advice

CAR T-Cell Mechanism of Action

Current FDA-Approved Autologous CAR T-Cell Therapies

Current FDA-Approved Autologous CAR T-Cell Therapies (cont)

Selecting Patients for CAR T-Cell Therapy

Weighing the Decision for CAR T-Cell Therapy

When to Refer Patients for CAR T-Cell Therapy

Preparing for CAR T-Cell Therapy: The Patient's Journey

CAR T-Cell Therapy Production

Considerations for CAR T-Cell Administration

Essentials for CAR T-Cell Therapy

Acute AEs of CAR T-Cell Therapy

Early Monitoring of CAR T-Cell Toxicity

Documenting Acute Toxicity for Rapid Response

Managing Toxicity: Keeping Pace With Best Practices

Grading CRS

Grading ICANS

Management of CRS

Management of ICANS

Better Communication = Better Outcomes

Late Toxicities of CAR T-Cell Therapy

Key Takeaways

Abbreviations

Abbreviations (cont)